Gary Clark: Unfiltered

Aligos Therapeutics secures a key partnership and regulatory fast-track in China, signaling a major financial and clinical validation for its novel HBV drug.

A personal health crisis sparks a revolutionary philanthropic model. Folded Hills Winery isn't just funding research; it's rewriting the rules of patient aid.

The Mass. Council on Economic Education endorses a new AP course, pushing for college-level financial literacy to become the new standard for all students.

As America prepares for its 250th anniversary, a new film highlights a silent crisis. 63 million unpaid caregivers form a $600B shadow economy facing collapse.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

Industrial giant Schouw & Co. acquires premium apparel maker Spectre, a strategic play to enter the booming technical sportswear market. Is this a perfect fit?

Active Care Group's new high-tech hospital isn't just about patient care. It's a strategic play where private equity, AI, and a hallowed legacy converge.

A major foundation is funding an innovative model to combat NC's maternal care deserts. Is this strategic philanthropy the future of fixing a broken system?

The AHN-Heritage Valley merger is more than a local headline. It's a calculated move in a regional healthcare war with billion-dollar stakes for competition.

From a struggling Bitcoin treasury, Empery Digital is betting $65M on an AI data center. Can a capital-light real estate play finally close its valuation gap?

Eric Jorgenson's 'The Book of Elon' arrives, promising an operating manual to Musk's success. But can a curated collection of quotes truly replicate genius?

With its iOS app approved, Hop-on Inc.'s Digitalage platform is live. Can its aggressive 85/15 revenue split and patent-pending tech reshape a $250B market?

Monitaur's Gartner nod signals a bigger story: the explosive growth of a new market built to tame AI before it breaks the global financial system.

Candel Therapeutics is betting its future on a pivotal Phase 3 trial for a novel viral immunotherapy, aiming to succeed where checkpoint inhibitors have failed.

Orazio Buzza's win isn't just about food. It's about a tech-driven solution to the office culture crisis, powered by logistics, AI, and local restaurants.

AFSP Illinois launches culturally-specific suicide prevention programs, revealing a crucial truth: addressing mental health disparities is an economic necessity.

OrangeX's shift to WOWX is more than a name change. It's a high-stakes gamble on compliance, hype, and a new trading philosophy. But will it work?

Hafnia's planned CEO transition from founder Mikael Skov to insider Søren Jensen signals a masterclass in stability and a deep bet on a digital, efficient future.

Vishay seeks a massive capital infusion to fund innovation and slash debt. We unpack the strategy, the market's nervous reaction, and what it means for the sector.

With FDA approval for its pivotal TRIUMPH trial, Laplace Interventional is challenging giants in the lucrative tricuspid valve market. A strategic play.